PRODUCT INFORMATION
Name : Artemether & Lumefantrine 20 120 Mg
ARTEMETHER & LUMEFANTRINE 20 120 MG
Artemether & Lumefantrine tablets is a fixed-dose combination tablet of artemether and lumefantrine. Artemether is a methyl ether derivative of dihydroartemisinin, derived from artemisinin. Lumefantrine is a racemic 2, 4, 7, 9-substituted fluorine derivative that conforms structurally, physicochemically and in mode of action to the arylamino alcohol group of antimalarials that includes quinine and mefloquine. INDICATIONS: Artemether & Lumefantrine tablets are indicated for treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients of 5 kg bodyweight and above. Artemether & Lumefantrine tablets have been shown to be effective in geographical regions where resistance to chloroquine has been reported. Limitations of Use: Artemether & Lumefantrine tablets are not approved for patients with severe or complicated P. falciparum malaria. CONTRAINDICATIONS: Artemether & Lumefantrine tablets are contraindicated in persons with a history of hypersensitivity associated with the use of artemether, lumefantrine, or to any of the excipients of Artemether & Lumefantrine tablets. STORAGE: Store in an airtight container, protected from light. PRESENTATION: 4X6 Tablets in one blister in a mono pack.
